Invivoscribe Expanding Clinical Laboratory Network Space and Testing Capabilities in San Diego, Germany, Japan, and China. Offering Comprehensive Standardized Testing for All Hematologic Malignancies

SAN DIEGO, May 23  (Bernama-GLOBE NEWSWIRE) — Invivoscribe, Inc., a vertically integrated global company focused on Improving Lives with Precision Diagnostics^®, today announces expansion of space and testing capabilities in their international network of accredited LabPMM^® clinical laboratories. Additions to the test menu will include morphology, IHC, flow cytometry, as well as the latest multiparameter flow- (MPF), and NGS-based minimal residual disease (MRD) testing of primary specimens. These new services will further support rapid patient diagnosis, study subject enrollment, and study subject stratifications. They will be available by end of this year in San Diego followed by the laboratories in Japan, Germany and China.

http://mrem.bernama.com/viewsm.php?idm=34612